Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis

Journal of the American Society of Nephrology : JASN
Riyaz MohamedGanesan Ramesh

Abstract

Diabetes is the leading cause of kidney failure, accounting for >45% of new cases of dialysis. Diabetic nephropathy is characterized by inflammation, fibrosis, and oxidant stress, pathologic features that are shared by many other chronic inflammatory diseases. The cytokine IL-17A was initially implicated as a mediator of chronic inflammatory diseases, but recent studies dispute these findings and suggest that IL-17A can favorably modulate inflammation. Here, we examined the role of IL-17A in diabetic nephropathy. We observed that IL-17A levels in plasma and urine were reduced in patients with advanced diabetic nephropathy. Type 1 diabetic mice that are genetically deficient in IL-17A developed more severe nephropathy, whereas administration of low-dose IL-17A prevented diabetic nephropathy in models of type 1 and type 2 diabetes. Moreover, IL-17A administration effectively treated, prevented, and reversed established nephropathy in genetic models of diabetes. Protective effects were also observed after administration of IL-17F but not IL-17C or IL-17E. Notably, tubular epithelial cell-specific overexpression of IL-17A was sufficient to suppress diabetic nephropathy. Mechanistically, IL-17A administration suppressed phosphorylat...Continue Reading

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J BehrensW Birchmeier
Sep 22, 2001·The New England Journal of Medicine·T H Hostetter
Dec 31, 2003·Trends in Immunology·Paresh DandonaArindam Bandyopadhyay
Oct 16, 2004·Immunity·Jay K Kolls, Anders Lindén
Feb 11, 2005·American Journal of Physiology. Renal Physiology·Ganesan Ramesh, W Brian Reeves
Apr 12, 2005·Advances in Chronic Kidney Disease·Nina Vasavada, Rajiv Agarwal
Jun 7, 2005·Journal of the American Society of Nephrology : JASN·Marie-Luise GrossEberhard Ritz
Jan 6, 2006·Journal of the American Society of Nephrology : JASN·Elena Galkina, Klaus Ley
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yutaka KomiyamaYoichiro Iwakura
Aug 8, 2006·Immunologic Research·Klaus LeyMatthew A Stark
Oct 12, 2007·Journal of the American Society of Nephrology : JASN·Sharma PrabhakarRuc Tran
Jan 25, 2008·American Journal of Physiology. Renal Physiology·Weiwei WangGanesan Ramesh
Apr 29, 2008·Current Opinion in Immunology·Christina L RoarkRebecca L O'Brien
Aug 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jill F WrightBeatriz M Carreno
Oct 11, 2008·Scandinavian Journal of Clinical and Laboratory Investigation·Hans-Jacob BangstadKristian F Hanssen
Dec 9, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Colin EdgertonGeorge C Tsokos
Dec 17, 2008·The Journal of Clinical Investigation·Stefan HaakAri Waisman
Sep 10, 2009·The Journal of Experimental Medicine·Soraya TalebZiad Mallat
Oct 31, 2009·Diabetes Research and Clinical Practice·Mohammad Kazemi ArababadiReza Derakhshan
Dec 30, 2009·Hypertension·Meena S MadhurDavid G Harrison
Apr 9, 2010·American Journal of Physiology. Renal Physiology·Hongyu ZhangFrank C Brosius
Apr 10, 2010·Circulation Research·G Christian BaldevianoDaniela Cihakova
Aug 17, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marcus KarlstetterThomas Langmann
Dec 15, 2010·Nature Reviews. Endocrinology·Dhruv K SinghKen Farrington
Jan 5, 2011·Cell Metabolism·Rebecca G BakerSankar Ghosh
Feb 9, 2011·Atherosclerosis·Xiang ChengYu-Hua Liao
Feb 11, 2011·Diabetes Care·Ferdau L NautaRon T Gansevoort
Mar 1, 2011·Journal of the American Society of Nephrology : JASN·Elizabeth T RosolowskyAndrzej S Krolewski
Mar 5, 2011·Kidney International. Supplement·Peter Rossing, Dick de Zeeuw
May 3, 2011·PloS One·Michal M PoplawskiCharles V Mobbs
Nov 26, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Keiko DanzakiToshimitsu Uede
Mar 10, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Taiji NakashimaHironobu Ihn
May 18, 2012·Nephrology·Lan NiPeter W Mathieson
Jun 8, 2012·The Journal of Investigative Dermatology·David A MartinChris B Russell
Jul 19, 2013·The Journal of Clinical Investigation·Neil B RudermanJosé M Cacicedo
Oct 19, 2013·The Journal of Clinical Investigation·Laura L DuganKumar Sharma
Sep 25, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Riyaz MohamedGanesan Ramesh
Sep 1, 2013·Emerging Microbes & Infections·Wei Jin, Chen Dong

❮ Previous
Next ❯

Citations

Sep 4, 2015·Journal of the American Society of Nephrology : JASN·Daniel L Galvan, Farhad R Danesh
Feb 14, 2017·Annual Review of Physiology·Sarah C Huen, Lloyd G Cantley
May 7, 2016·World Journal of Nephrology·Usama Abdel Azim Sharaf El DinDina Ossama Abdulazim
Oct 20, 2018·Expert Opinion on Investigational Drugs·Juan Antonio MorenoJesus Egido
Dec 6, 2018·The Journal of Physiology·Hong ChenKun Huang
Jan 9, 2016·The European Respiratory Journal·Katharina L BeckerFrank L van de Veerdonk
Jul 4, 2018·British Journal of Pharmacology·Gisele Facholi BomfimFernando S Carneiro
Jan 23, 2020·Journal of Clinical Medicine·Carolina LavozMarta Ruiz-Ortega
May 31, 2020·International Journal of Molecular Sciences·Sandra Rayego-MateosJesús Egido
Sep 15, 2020·American Journal of Physiology. Renal Physiology·Purvi MehrotraDavid P Basile
Feb 21, 2019·Scientific Reports·Jin MaHuiling Wu
Jul 31, 2019·American Journal of Physiology. Endocrinology and Metabolism·Rong DongYan Zha
Apr 23, 2020·International Journal of Molecular Sciences·Priscila Calle, Georgina Hotter
Aug 2, 2017·Clinical Science·Greg H Tesch
Mar 14, 2018·Current Diabetes Reports·Fionnuala B Hickey, Finian Martin
Dec 7, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Sha DiXiaolin Tong
Sep 14, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Jun JiangGuoyuan Lu
May 11, 2019·Rheumatology International·Sakir AhmedVikas Agarwal
May 6, 2019·International Journal of Molecular Sciences·Laura Katharina Sievers, Kai-Uwe Eckardt
Feb 9, 2021·Frontiers in Medicine·Javier Donate-CorreaJuan F Navarro-González
Sep 2, 2020·Cardiovascular Research·Akinori HigakiErnesto L Schiffrin
Apr 2, 2021·Kidney Research and Clinical Practice·David P BasilePurvi Mehrotra
Jul 6, 2021·Disease Markers·Youdi WangJialin Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here